avatar
KIYATEC

    Greenville, SC, USA

    Founded September 2005

    C Corporation

    Pharmaceuticals

Description
We leverage our proprietary ex vivo 3D cell culture technology platforms to accurately model and predict response to approved and investigational cancer drugs targeting a spectrum of solid tumors. Drug Development Services: We work with leading biopharmaceutical companies to unlock response dynamics (ex vivo efficacy) for their investigational cancer drug candidates in preclinical testing and subsequent clinical trials. Clinical Testing Services (CLIA-certified laboratory): In 2019 we published of our assay’s analytical validation and clinical evidence of its predictive performance. Currently we are further validating drug response-predictive clinical assays as well as undertaking investigator-initiated studies in ovarian cancer, high-grade glioma, breast cancer and rare tumors.
Updates Feed

    Today

    • Note Lorem

      Public
    • Document Lorem

      document.pdf
      1
      Public
    • Announcement Lorem

      Public

Contact us to see more data and start a conversation.

Already a user? Log in